1 Min Read
Dec 6 (Reuters) - ProMIS Neurosciences Inc
* Promis neurosciences announces novel alzheimer’s disease therapeutic candidates block neurotoxicity of prion-like forms of amyloid beta Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.